UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (3), p.274-285

2011

Volltextzugriff (PDF)

Associations of chronic hepatitis C with metabolic and cardiac outcomes

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (6), p.647-652

2013

Volltextzugriff (PDF)

Systematic review: patient‐reported outcomes in chronic hepatitis C ‐ the impact of liver disease and new treatment regimens

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (6), p.497-520

2015

Volltextzugriff (PDF)

Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis

Alimentary pharmacology & therapeutics, 2008-07, Vol.28 (1), p.2-12

YOUNOSSI, Z. M.

2008

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity

Gastroenterology (New York, N.Y. 1943), 1999-06, Vol.116 (6), p.1413-1419

1999

Volltextzugriff (PDF)

Adipokines and cytokines in non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2008-03, Vol.27 (5), p.412-421

2008

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study

Alimentary pharmacology & therapeutics, 2012-10, Vol.36 (8), p.772-781

2012

Volltextzugriff (PDF)

Caffeine is protective in patients with non-alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.76-82

2012

Volltextzugriff (PDF)

Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection—Author's reply

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.537-538

Younossi, Z. M.

2018

Volltextzugriff (PDF)

Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2011-04, Vol.33 (7), p.801-814

2011

Volltextzugriff (PDF)

Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (6), p.544-563

2015

Volltextzugriff (PDF)

The impact of type 2 diabetes and obesity on the long‐term outcomes of more than 85 000 liver transplant recipients in the US

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.686-694

2014

Volltextzugriff (PDF)

Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets

Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (1), p.3-14

2014

Volltextzugriff (PDF)

A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection

Journal of viral hepatitis, 2015-11, Vol.22 (11), p.897-905

2015

Volltextzugriff (PDF)

The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon‐ and ribavirin‐free regimens: a study of health‐related quality of life

Alimentary pharmacology & therapeutics, 2015-08, Vol.42 (3), p.286-295

2015

Volltextzugriff (PDF)

The impact of hepatitis C burden: an evidence‐based approach

Alimentary pharmacology & therapeutics, 2014-03, Vol.39 (5), p.518-531

2014

Volltextzugriff (PDF)

Differential expression of miRNAs in the visceral adipose tissue of patients with non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2010-08, Vol.32 (3), p.487-497

2010

Volltextzugriff (PDF)

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

Gut, 1999-08, Vol.45 (2), p.295-300

1999

Volltextzugriff (PDF)

Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (5), p.680-688

2018

Volltextzugriff (PDF)

Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2013-04, Vol.37 (7), p.703-709

2013

Volltextzugriff (PDF)

Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (2), p.259-267

2018

Volltextzugriff (PDF)

Predictors of health‐related quality of life in patients with chronic liver disease

Alimentary pharmacology & therapeutics, 2009-09, Vol.30 (5), p.469-476

2009

Volltextzugriff (PDF)

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

Journal of viral hepatitis, 2018-08, Vol.25 (8), p.945-951

2018

Volltextzugriff (PDF)

Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.857-865

2016

Volltextzugriff (PDF)

Patients' preferences and health utility assessment with SF‐6D and EQ‐5D in patients with chronic hepatitis C treated with sofosbuvir regimens

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.676-685

2014

Volltextzugriff (PDF)

1 – 25 von 387

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(379)
Mit Volltextzugriff
(334)

Publikationsform

Sprache

Englisch
(380)
Deutsch
(8)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(175)
Science & Technology
(175)
Humans
(170)
Gastroenterology & Hepatology
(136)
Female
(110)
Male
(110)
Middle Aged
(98)
Adult
(79)
Biological And Medical Sciences
(74)
Medical Sciences
(73)
Gastroenterology And Hepatology
(71)
Infectious Diseases
(49)
Aged
(44)
Pharmacology & Pharmacy
(43)
Hepatitis C, Chronic - Drug Therapy
(41)
Quality Of Life
(39)
Antiviral Agents - Therapeutic Use
(35)
Gastroenterology. Liver. Pancreas. Abdomen
(33)
Drug Therapy, Combination
(30)
Hepatitis C
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Associations of chronic hepatitis C with metabolic and cardiac outcomes

Systematic review: patient‐reported outcomes in chronic hepatitis C ‐ the impact of liver disease and new treatment regimens

Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity

Adipokines and cytokines in non‐alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study

Caffeine is protective in patients with non-alcoholic fatty liver disease

Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection—Author's reply

Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non‐alcoholic fatty liver disease

Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

The impact of type 2 diabetes and obesity on the long‐term outcomes of more than 85 000 liver transplant recipients in the US

Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets

A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection

The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon‐ and ribavirin‐free regimens: a study of health‐related quality of life

The impact of hepatitis C burden: an evidence‐based approach

Differential expression of miRNAs in the visceral adipose tissue of patients with non‐alcoholic fatty liver disease

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality

Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C

Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3

Predictors of health‐related quality of life in patients with chronic liver disease

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus

Patients' preferences and health utility assessment with SF‐6D and EQ‐5D in patients with chronic hepatitis C treated with sofosbuvir regimens

Suchergebnisse filtern